We found that FBL expressions in CD19+ B cells and CD4+ T cells of SLE patients were lower than that of healthy controls (Supplementary Figures 3B, C), suggesting that FBL may play an immunomodulatory role. This evidence concerns the gene FBL and systemic lupus erythematosus.